Join industry expert Adam J. Fein, PhD, as he helps the industry navigate this challenging and dynamic period in U.S. drug channels. During this interactive virtual session, Dr. Fein will explain the key trends reshaping U.S. drug channels, examine the emergence of organized market access channels, highlight business and marketing implications for generic and biosimilar medicines, and discuss strategic implications and the industry outlook. Dr. Fein will also be taking your questions during his session on Thursday, May 27.
Learn more or register at: https://access.accessiblemeds.org/